US Patent Issued to EUROIMMUN Medizinische Labordiagnostika on July 29 for "Method for detecting a binding of antibodies from a patient sample to double-stranded DNA using Crithidia luciliae cells and fluorescence microscopy" (German Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,372,532, issued on July 29, was assigned to EUROIMMUN Medizinische Labordiagnostika AG (Lubeck, Germany).

"Method for detecting a binding of antibodies from a patient sample to double-stranded DNA using Crithidia luciliae cells and fluorescence microscopy" was invented by Stefan Gerlach (GroB Groenau, Germany), Jens Krauth (Lubeck, Germany), Christian Marzahl (Erlangen, Germany), Christopher Krause (Buchen, Germany), Maick Danckwardt (Rondeshagen, Germany), Melanie Hahn (Stockelsdorf, Germany) and Jorn Voigt (Lubeck, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is proposed a method for detecting a binding of autoantibodies from a patient...